David Spiegelhalter
#5,333
Most Influential Person Now
British mathematician
David Spiegelhalter's AcademicInfluence.com Rankings
David Spiegelhaltermathematics Degrees
Mathematics
#1102
World Rank
#1870
Historical Rank
Statistics
#64
World Rank
#90
Historical Rank
Measure Theory
#238
World Rank
#370
Historical Rank
Download Badge
Mathematics
Why Is David Spiegelhalter Influential?
(Suggest an Edit or Addition)According to Wikipedia, Sir David John Spiegelhalter is a British statistician and a Fellow of Churchill College, Cambridge. From 2007 to 2018 he was Winton Professor of the Public Understanding of Risk in the Statistical Laboratory at the University of Cambridge. Spiegelhalter is an ISI highly cited researcher.
David Spiegelhalter's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Bayesian measures of model complexity and fit (2002) (11842)
- WinBUGS - A Bayesian modelling framework: Concepts, structure, and extensibility (2000) (5709)
- Local computations with probabilities on graphical structures and their application to expert systems (1990) (4409)
- Markov Chain Monte Carlo in Practice (1997) (4052)
- Machine Learning, Neural and Statistical Classification (2009) (2772)
- Probabilistic Networks and Expert Systems (1999) (1980)
- The BUGS project: Evolution, critique and future directions (2009) (1939)
- A re-evaluation of random-effects meta-analysis (2009) (1695)
- League Tables and Their Limitations: Statistical Issues in Comparisons of Institutional Performance (1996) (1095)
- Risk perceptions of COVID-19 around the world (2020) (1084)
- Bayesian analysis in expert systems (1993) (800)
- The BUGS Book: A Practical Introduction to Bayesian Analysis (2012) (762)
- Funnel plots for comparing institutional performance (2005) (751)
- A Language and Program for Complex Bayesian Modelling (1994) (745)
- WinBUGS user manual version 1.4 (2003) (743)
- Quality of life measures in health care. I: Applications and issues in assessment. (1992) (717)
- Introducing Markov chain Monte Carlo (1995) (664)
- Sequential updating of conditional probabilities on directed graphical structures (1990) (629)
- BUGS - Bayesian inference Using Gibbs Sampling Version 0.50 (1995) (566)
- Bayesian approaches to random-effects meta-analysis: a comparative study. (1995) (551)
- Visualizing Uncertainty About the Future (2011) (529)
- Inference and monitoring convergence (1995) (508)
- The deviance information criterion: 12 years on (2014) (494)
- Use and misuse of process and outcome data in managing performance of acute medical care: avoiding institutional stigma (2004) (479)
- Markov chain concepts related to sampling algorithms (1995) (391)
- Bayesian Approaches to Clinical Trials and Health-Care Evaluation: Spiegelhalter/Clinical Trials and Health-Care Evaluation (2004) (385)
- Statistical and Knowledge‐Based Approaches to Clinical Decision‐Support Systems, with an Application in Gastroenterology (1984) (382)
- Bayesian methods in health technology assessment: a review. (2000) (368)
- Quality‐Of‐Life Assessment: Can We Keep it Simple? (1992) (365)
- Probabilistic prediction in patient management and clinical trials. (1986) (354)
- Infant wellbeing at 2 years of age in the Growth Restriction Intervention Trial (GRIT): multicentred randomised controlled trial (2004) (344)
- Bayes Factors and Choice Criteria for Linear Models (1980) (340)
- Disease Mapping With WinBUGS and MLwiN, Bayesian Approaches to Clinical Trials and Health Care Evaluation (2004) (328)
- Quality of life measures in health care. II: Design, analysis, and interpretation. (1992) (321)
- Bayes Factors for Linear and Log‐Linear Models with Vague Prior Information (1982) (312)
- Laparoscopic versus open inguinal hernia repair: randomised prospective trial (1994) (309)
- Bayesian Approaches to Randomized Trials (1994) (299)
- Use of risk-adjusted CUSUM and RSPRTcharts for monitoring in medical contexts (2003) (287)
- An introduction to bayesian methods in health technology assessment (1999) (284)
- Bias modelling in evidence synthesis (2009) (283)
- Probabilistic Networks and Expert Systems - Exact Computational Methods for Bayesian Networks (1999) (277)
- Hypothesis testing and model selection (1995) (274)
- A randomised trial of timed delivery for the compromised preterm fetus: short term outcomes and Bayesian interpretation. (2003) (270)
- A predictive approach to selecting the size of a clinical trial, based on subjective clinical opinion. (1986) (259)
- Summarizing historical information on controls in clinical trials (2010) (253)
- Robust meta‐analytic‐predictive priors in clinical trials with historical control information (2014) (252)
- Evaluating medical expert systems: what to test and how? (1990) (243)
- Monitoring clinical trials: conditional or predictive power? (1986) (243)
- Issues in data monitoring and interim analysis of trials. (2005) (237)
- Risk-adjusted sequential probability ratio tests: applications to Bristol, Shipman and adult cardiac surgery. (2003) (235)
- Bayesian approaches to multiple sources of evidence and uncertainty in complex cost‐effectiveness modelling (2003) (222)
- Field trials of medical decision-aids: potential problems and solutions. (1991) (208)
- A Collaboratively-Derived Science-Policy Research Agenda (2012) (207)
- Modelling Complexity: Applications of Gibbs Sampling in Medicine (1993) (203)
- Reliability of league tables of in vitro fertilisation clinics: retrospective analysis of live birth rates. (1998) (199)
- Observer variation and discriminatory value of biopsy features in inflammatory bowel disease. (1994) (189)
- Flexible random‐effects models using Bayesian semi‐parametric models: applications to institutional comparisons (2007) (185)
- Communicating uncertainty about facts, numbers and science (2019) (183)
- Bayesian model comparison via jump diffusions (1995) (182)
- Bayesian random effects meta‐analysis of trials with binary outcomes: methods for the absolute risk difference and relative risk scales (2002) (163)
- Bayesian deviance the e ective number of parameters and the comparison of arbitrarily complex models (1998) (162)
- Introduction to general state-space Markov chain theory (1995) (162)
- Don't know, can't know: embracing deeper uncertainties when analysing risks (2011) (158)
- Bayesian Analysis of Population PK/PD Models: General Concepts and Software (2002) (157)
- Probabilistic Reasoning in Predictive Expert Systems (1985) (154)
- Handling uncertainty in housing stock models (2012) (151)
- Bayesian mapping of disease (1995) (150)
- Screening for Treatable Diabetic Retinopathy: a Comparison of Different Methods (1991) (147)
- Approximate cross‐validatory predictive checks in disease mapping models (2003) (145)
- Bayesian graphical modelling: a case‐study in monitoring health outcomes (2002) (141)
- Incorporating Bayesian Ideas into Health-Care Evaluation (2004) (140)
- A note on the power prior (2009) (139)
- The effects of communicating uncertainty on public trust in facts and numbers (2020) (135)
- Handling over-dispersion of performance indicators (2005) (135)
- Bayesian Analysis of Realistically Complex Models (1996) (132)
- Full conditional distributions (1995) (130)
- Etanercept, infliximab and adalimumab for the treatment of psoriatic arthritis: a systematic review and economic evaluation. (2011) (129)
- Statistical methods for healthcare regulation: rating, screening and surveillance (2012) (127)
- A statistical view of uncertainty in expert systems (1986) (126)
- Principles for Best Practice in Clinical Audit (124)
- Risk and Uncertainty Communication (2017) (121)
- Being sceptical about meta-analyses: a Bayesian perspective on magnesium trials in myocardial infarction. (2002) (121)
- Applying Bayesian ideas in drug development and clinical trials. (1993) (120)
- Mixtures of distributions: inference and estimation (1995) (118)
- Model checking and model improvement (1995) (117)
- Information visualisation for science and policy: engaging users and avoiding bias. (2014) (116)
- Bayesian methods for cluster randomized trials with continuous responses. (2001) (113)
- Funnel plots for institutional comparison (2002) (112)
- Comparison of UK paediatric cardiac surgical performance by analysis of routinely collected data 1984–96: was Bristol an outlier? (2001) (111)
- VIBES: A Variational Inference Engine for Bayesian Networks (2002) (110)
- An analysis of repeated biopsies following cardiac transplantation. (1983) (109)
- COVID-19 risk perception: a longitudinal analysis of its predictors and associations with health protective behaviours in the United Kingdom (2021) (109)
- The CHART trials: Bayesian design and monitoring in practice. CHART Steering Committee. (1994) (109)
- Mortality and volume of cases in paediatric cardiac surgery: retrospective study based on routinely collected data (2002) (105)
- The Assessment of the Subjective Opinion and its Use in Relation to Stopping Rules for Clinical Trials (1983) (100)
- Quality of life measures in health care. III: Resource allocation. (1992) (98)
- Policy: Twenty tips for interpreting scientific claims (2013) (98)
- TUTORIAL IN BIOSTATISTICS SURVIVAL ANALYSIS IN OBSERVATIONAL STUDIES (1997) (98)
- Comparison of Bayesian with group sequential methods for monitoring clinical trials. (1989) (97)
- Surgical audit: statistical lessons from Nightingale and Codman (1999) (95)
- The what, why and how of Bayesian clinical trials monitoring. (1994) (95)
- Identifying outliers in Bayesian hierarchical models: a simulation-based approach (2007) (93)
- Aspirin, paracetamol, and haematemesis and melaena. (1982) (91)
- Analysis of longitudinal binary data from multiphase sampling (1998) (91)
- All-cause mortality (2011) (90)
- The legacy of Bristol: public disclosure of individual surgeons' results (2004) (84)
- Hepatitis B: a case study in MCMC methods (1996) (84)
- The ProActive trial protocol – a randomised controlled trial of the efficacy of a family-based, domiciliary intervention programme to increase physical activity among individuals at high risk of diabetes [ISRCTN61323766] (2004) (83)
- Combining MCMC with ‘sequential’ PKPD modelling (2009) (83)
- Assessment, Criticism and Improvement of Imprecise Subjective Probabilities for a Medical Expert System (2013) (82)
- A database on dyspepsia. (1994) (80)
- Bayesian measures of model omplexity and t (2001) (80)
- Monitoring of large randomised clinical trials: a new approach with Bayesian methods (2001) (79)
- A Simple Risk-Adjusted Exponentially Weighted Moving Average (2007) (75)
- Stochastic search variable selection (1995) (74)
- The Identification of “Unusual” Health-Care Providers From a Hierarchical Model (2011) (74)
- Use of the false discovery rate when comparing multiple health care providers. (2008) (74)
- Estimating the True Extent of Cognitive Decline in the Old Old (1999) (74)
- Use of “normal” risk to improve understanding of dangers of covid-19 (2020) (70)
- Commissioned analysis of surgical performance using routine data: lessons from the Bristol inquiry (2002) (69)
- How valuable are multiple treatment comparison methods in evidence-based health-care evaluation? (2011) (68)
- Screening for diabetic retinopathy: a relative cost-effectiveness analysis of alternative modalities and strategies. (1992) (66)
- An Overview of the Bayesian Approach (2004) (66)
- Conservative treatment of mild/moderate cervical dyskaryosis: long-term outcome (1992) (65)
- A hierarchical Bayesian framework for calibrating micro-level models with macro-level data (2013) (65)
- Systematic qualitative review of the literature on data monitoring committees for randomized controlled trials (2004) (65)
- Inferences from multinomial data: Learning about a bag of marbles - Discussion (1996) (63)
- A hierarchical modelling framework for identifying unusual performance in health care providers (2007) (62)
- Sequential Model Criticism in Probabilistic Expert Systems (1993) (60)
- The ASA's p‐value statement, one year on (2017) (60)
- Shielding from covid-19 should be stratified by risk (2020) (60)
- What determines the cost-effectiveness of diabetes screening? (2006) (59)
- Prior distributions for the intracluster correlation coefficient, based on multiple previous estimates, and their application in cluster randomized trials (2005) (58)
- "Ulcer--like dyspepsia". (1982) (57)
- How does computer-aided diagnosis improve the management of acute abdominal pain? (1992) (57)
- Five rules for evidence communication (2020) (57)
- MCMC for nonlinear hierarchical models (1995) (55)
- A Relative Cost‐effectiveness Analysis of Different Methods of Screening for Diabetic Retinopathy (1991) (54)
- Multiple-bias modelling for analysis of observational data - Discussion (2005) (52)
- Reported use of data monitoring committees in the main published reports of randomized controlled trials: a cross-sectional study (2004) (51)
- Evaluation of clinical decision-aids, with an application to a system for dyspepsia. (1983) (50)
- Incorporation of uncertainty in health economic modelling studies (2012) (49)
- Routine Antenatal Anti-D Prophylaxis in Women Who Are Rh(D) Negative: Meta-Analyses Adjusted for Differences in Study Design and Quality (2012) (48)
- Components of variance in a multicentre functional MRI study and implications for calculation of statistical power (2008) (48)
- Raising concerns about family history of breast cancer in primary care consultations: prospective, population based study (2001) (47)
- Predicting difficult intubation. (1989) (47)
- Microarrays, Empirical Bayes and the Two-Groups Model. Comment. (2008) (47)
- Twenty tips for interpreting scientific claims (2013) (47)
- Application of Bayesian statistics to decision making during a clinical trial. (1992) (46)
- Risk of intracranial aneurysm bleeding in autosomal-dominant polycystic kidney disease. (2007) (45)
- Bayesian networks for patient monitoring (1992) (42)
- MCMC in image analysis (1995) (42)
- Statistical methodology for evaluating gastrointestinal symptoms. (1985) (41)
- How old are you, really? Communicating chronic risk through ‘effective age’ of your body and organs (2016) (41)
- Conflict Diagnostics in Directed Acyclic Graphs, with Applications in Bayesian Evidence Synthesis (2013) (40)
- Survival analysis in observational studies. (1997) (39)
- Tricuspid Atresia Presenting in Infancy Survival and Suitability for the Fontan Operation (1993) (39)
- A test for normality against symmetric alternatives (1977) (37)
- Implications for trials in progress of publication of positive results (1993) (36)
- BREAST CANCER IN THYROID DISEASE: FACT OR FALLACY? (1981) (35)
- Empirical evaluation of prior beliefs about frequencies : methodology and a case study in congenital heart disease (1994) (35)
- Problems in assessing rates of infection with methicillin resistant Staphylococcus aureus (2005) (35)
- Implementing informative priors for heterogeneity in meta‐analysis using meta‐regression and pseudo data (2016) (34)
- Conflicting evidence in a Bayesian synthesis of surveillance data to estimate human immunodeficiency virus prevalence (2008) (34)
- A unified method for monitoring and analysing controlled trials. (1994) (34)
- Impact of plain packaging of tobacco products on smoking in adults and children: an elicitation of international experts’ estimates (2013) (33)
- Patient reactions to a web-based cardiovascular risk calculator in type 2 diabetes: a qualitative study in primary care (2015) (32)
- Two types of trichromatic squirrel monkey share a pigment in the red-green spectral region (1985) (32)
- An Empirical Approximation to the Null Unbounded Steady-State Distribution of the Cumulative Sum Statistic (2008) (31)
- Should We Trust Algorithms? (2020) (31)
- ‘Careless pork costs lives’: Risk stories from science to press release to media (2011) (30)
- Cancer Drugs Fund requires further reform (2016) (30)
- Prospective application of Bayesian monitoring and analysis in an ‘open’ randomized clinical trial (2001) (29)
- The future lies in uncertainty (2014) (29)
- Intracortically distributed neurovascular coupling relationships within and between human somatosensory cortices. (2006) (28)
- Monitoring clinical performance: a commentary. (2004) (28)
- Estimation of population pharmacokinetics using the Gibbs sampler (1995) (27)
- Consensus and controversy in pharmaceutical statistics - Discussion (2000) (27)
- Development of a Transparent Interactive Decision Interrogator to Facilitate the Decision-Making Process in Health Care (2011) (27)
- Dopaminergic effects on electrophysiological and functional MRI measures of human cortical stimulus–response power laws (2004) (26)
- Using speed of ageing and “microlives” to communicate the effects of lifetime habits and environment (2012) (25)
- Statistical Aids in Clinical Decision-making (1982) (24)
- Accounting for regression‐to‐the‐mean in tests for recent changes in institutional performance: Analysis and power (2009) (23)
- The Art of Statistics: Learning from Data (2019) (23)
- Local and marginal control charts applied to methicillin resistant Staphylococcus aureus bacteraemia reports in UK acute National Health Service trusts (2009) (23)
- Changing patterns of coeliac disease frequency: an analysis of Coeliac Society membership records. (1985) (23)
- Rejoinder to commentaries on ‘The BUGS project: Evolution, critique and future directions’ (2009) (23)
- Modelling bias in combining small area prevalence estimates from multiple surveys (2011) (22)
- Bicycle helmets and the law (2013) (22)
- Management of Women With A Cervical Smear Showing A Mild Degree of Dyskaryosis: A Review of Policy (1992) (22)
- An omnibus test for normality for small samples (1980) (22)
- Taking a calculated risk: predictive scoring systems in dyspepsia. (1987) (22)
- What Can Education Learn from Real-World Communication of Risk and Uncertainty? (2015) (22)
- Bayesian statistics (2009) (22)
- The value of clinical, biochemical, ultrasound and liver biopsy data in assessing patients with liver disease. (2008) (22)
- Flexible Design and Efficient Implementation of Adaptive Dose-Finding Studies (2007) (22)
- Analgesic intake and the risk of acute upper gastrointestinal bleeding. (1983) (21)
- How to interpret your dot: decoding the message of clinical performance indicators (2008) (21)
- Computerized Aids for Probabilistic Assessment of Drug Safety I: A Spreadsheet Program* (1991) (21)
- Trends in Invasive Cervical Cancer Incidence in East Anglia from 1971 to 1993 (1997) (21)
- Are you 45% more likely to die in a UK hospital rather than a US hospital? (2013) (21)
- The pros and cons of funnel plots as an aid to risk communication and patient decision making. (2015) (20)
- Using routine intelligence to target inspection of healthcare providers in England (2009) (20)
- Domiciliary thrombolysis by general practitioners. (1992) (20)
- Understanding Uncertainty (2008) (19)
- A Unified Approach to Imprecision and Sensitivity of Beliefs in Expert Systems (1987) (19)
- Risk stratification for open heart surgery. (1992) (19)
- Coherent evidence propagation in expert systems (1987) (19)
- [Probabilistic Expert Systems in Medicine: Practical Issues in Handling Uncertainty]: Comment (1987) (18)
- Comment: Microarrays, Empirical Bayes and the Two-Groups Model (2008) (18)
- Gibbs sampling methods in genetics (1995) (18)
- Markov Chain Monte Carlo in practica (1996) (18)
- Statistical issues in studies of individual response. (1988) (17)
- How well did experts and laypeople forecast the size of the COVID-19 pandemic? (2021) (17)
- interventions to improve health Framework for design and evaluation of complex (2008) (17)
- Improved probabilistic prediction of healthcare performance indicators using bidirectional smoothing models (2012) (17)
- Winners and losers: communicating the potential impacts of policies (2018) (17)
- Trust in numbers (2017) (16)
- The adverse effects of bisphosphonates in breast cancer: A systematic review and network meta-analysis. (2021) (15)
- Bayesian Networks Applied to Therapy Monitoring (1994) (15)
- Allowing for correlations between correlations in random-effects meta-analysis of correlation matrices. (2007) (15)
- Have there been 13 000 needless deaths at 14 NHS trusts? (2013) (14)
- Communicating personalized risks from COVID-19: guidelines from an empirical study (2020) (14)
- Diagnostic systems by model selection: a case study (1994) (13)
- Conducting fit‐for‐purpose food safety risk assessments (2019) (13)
- Ranking institutions. (2003) (13)
- [Bayesian Analysis in Expert Systems]: Rejoinder (1993) (13)
- Diagnostic tests of distributional shape (1983) (12)
- The Norm Chronicles: Stories and Numbers About Danger and Death (2014) (12)
- Health economics and the search for shunt-responsive symptomatic hydrocephalus in the elderly. (2006) (12)
- BUGS 0 . 6 Bayesian inference Using Gibbs Sampling ( Addendum to Manual ) (1997) (12)
- A Bayesian dynamic model for influenza surveillance (2006) (11)
- Computer aided decision making in medicine. (1984) (11)
- A Bayesian expert system for the analysis of an adverse drug reaction (1991) (11)
- Advances in Neural Information Processing Systems 15 (NIPS 2002) (2002) (11)
- Computerized Aids for Probabilistic Assessment of Drug Safety II: An Expert System* (1991) (11)
- Fairness of financial penalties to improve control of Clostridium difficile (2008) (11)
- USE OF IMPLICIT AND EXPLICIT BAYESIAN METHODS IN HEALTH TECHNOLOGY ASSESSMENT (2013) (11)
- Cytotoxic Chemotherapy Monitoring Using Stochastic Simulation on Graphical Models (1991) (10)
- Comment: Citation Statistics (2009) (10)
- Responses to “An AI view of the treatment of uncertainty” by Alessandro Saffiotti (1988) (10)
- Simple and Multistate Survival Curves (2012) (10)
- Probabilistic reasoning in expert systems (1991) (10)
- To catheterise or not to catheterise? An approach based on decision theory. (1984) (9)
- An archaeological example: radiocarbon dating (1995) (9)
- Improving risk adjustment in the PRAiS (Partial Risk Adjustment in Surgery) model for mortality after paediatric cardiac surgery and improving public understanding of its use in monitoring outcomes (2017) (8)
- DIAGNOSIS, AND BAYES' THEOREM (1985) (8)
- A Simple Diagnostic Plot Connecting Robust Estimation, Outlier Detection, and False Discovery Rates (2006) (8)
- Cost‐Effectiveness, Policy‐Making and Regulation (2004) (7)
- Shipman's statistical legacy (2004) (7)
- Computers, Expert Systems, and ADRs: Can Causality Assessment Be Automated? (1986) (7)
- Comparing comprehension and perception for alternative speed‐of‐ageing and standard hazard ratio formats (2018) (7)
- Hormone replacement therapy and the risk of breast cancer: How much should women worry about it? (2019) (7)
- Risk: Quantifying uncertainty (2011) (7)
- Barriers to Health Information and Building Solutions (2011) (7)
- Probabilistic expert systems and graphical modelling: a case study in drug safety (1991) (7)
- Using an online game to evaluate effective methods of communicating ensemble model output to different audiences (2011) (7)
- Making sense of uncertainty: why uncertainty is part of science (2013) (6)
- One match to go! (2009) (6)
- The Null Steady-State Distribution of the CUSUM Statistic (2007) (6)
- Selecting Models from Data : AI and statistics IV (1995) (6)
- Bayesian networks for the analysis of drug safety (1993) (6)
- The mystery of the lost star: A statistical detective story (2005) (6)
- Introducing The Art of Statistics: How to Learn from Data (2019) (5)
- 18 The effects of communicating uncertainty about facts and numbers (2018) (5)
- London murders: a predictable pattern? (2009) (5)
- Criticizing Conditional Probabilities in Belief Networks (1990) (5)
- Strategies for inference robustness in focused modelling (2006) (5)
- Statistical reasoning and learning in knowledge-bases represented as causal networks (1988) (5)
- Score and ignore: A radio listener's guide to ignoring health stories (2012) (5)
- Computers and the diagnosis of acute abdominal pain. (1989) (5)
- Techniques for Bayesian analysis in expert systems (1990) (5)
- Communicating health risks in science publications: time for everyone to take responsibility (2018) (5)
- Redevelopment of the Predict: Breast Cancer website and recommendations for developing interfaces to support decision‐making (2021) (4)
- Bacon sandwiches and middle – class drinkers: the risk of communicating risk (2008) (4)
- The Evaluation of Medical Expert Systems (1992) (4)
- Improving society's management of risks - a statement of principles (2019) (4)
- Doctors' attitudes to risk in difficult clinical decisions: application of decision analysis in hepatobiliary disease. (1984) (4)
- Treatment decisions in breast cancer. (1988) (4)
- assessment introduction to bayesian methods in health Methods in health service research (1999) (3)
- THYROID DISEASE AND BREAST CANCER (1981) (3)
- UNCONSCIOUS PERCEPTION DURING GENERAL ANAESTHESIA (1987) (3)
- Stochastic EM: method and application (1995) (3)
- Performance measurement for health system improvement: Clinical surveillance and patient safety (2010) (3)
- Hepatitis B: A Case Study in MCMC (1998) (3)
- Spiegelhalter Visualizing Uncertainty About the Future (2011) (3)
- Sound human, steer clear of jargon, and be prepared (2021) (3)
- Expert derived automatically generated classification trees: an example from pediatric cardiology (1993) (3)
- A predictive approach to selecting the size of a clinical trial, based on subjective clinical opinion. (1988) (3)
- Making prognostic algorithms useful in shared decision-making: Patients and clinicians requirements for the Predict:Breast Cancer interface (2020) (2)
- What is my covid risk? (2021) (2)
- Have London's roads become more dangerous for cyclists? (2013) (2)
- Comparison of Alternative Approaches to Inference (2004) (2)
- Field trials ofmedical decision-aids: potential problems andsolutions (1992) (2)
- Fear and numbers in Fukushima (2011) (2)
- Validation and testing of medical decision aids. Introduction. (1990) (2)
- Basic Concepts from Traditional Statistical Analysis (2004) (2)
- The logical description of a disease class as a Boolean function with special reference to the irritable bowel syndrome. (1984) (2)
- Why risk is a risky business (2009) (1)
- Discussion of Presidential address: Statistics in times of increasing uncertainty by Sylvia Richardson (2022) (1)
- Costs used in the York model (2011) (1)
- Randomised Controlled Trials (2004) (1)
- Probabilistic methods and the interface with statistics (1990) (1)
- AWARENESS DURING ANAESTHESIA (1969) (1)
- Women's concern study group- Raising concersn about family history of breast cancer in primary care consultations: prospective population study (2001) (1)
- The Development of a Diagnostic Decision System (1982) (1)
- Bicycle helmets and the law: Canadian legislation had minimal effect on serious head injuries (2013) (1)
- Discussion (2006) (1)
- Breast implants: The scandal, the outcry, and assessing the risks (2012) (1)
- Monitoring the introduction of a surgical intervention with long‐term consequences (2007) (1)
- Sequential use of biologic therapy (2011) (1)
- Implications of using different types of priors in a three-level hierarchical Bayesian Model for the analysis of Drug Adverse Events. (2008) (1)
- Quality assessment tool (2011) (1)
- Cancer Drugs Fund requires further reform : Reliance on “real world” observational data undermines evidence base for clinical practice (2016) (1)
- Sex‐rated statistics (2015) (1)
- The contagious diseases acts: A controlled experiment in criminal justice (2004) (1)
- Monitoring clinical performance: invited comments on the papers by Grigg and Farewell and Marshall et al. (2004) (1)
- On wasps and club dinners (2004) (1)
- ‘Pure chance’, Probability and the Regulation of Gambling (2017) (1)
- Teaching probabilistic expert system using clinical data (1991) (0)
- 49 The basis of evidence-informed policymaking: communicating the potential impacts of policies (2018) (0)
- Estimation and optimization of functions (1995) (0)
- Public or private health care? (2005) (0)
- Book Reviews : Medical Uses of Statistics. EDITED BY JOHN C. BAILAR, III, AND FREDERICK MOSTELLER. Waltham, MA, New England Journal of Medicine Press, 1986. 425 pages. $35.00 (1987) (0)
- Citation Statistics (discussion for Statistical Science) (0)
- Withdrawal rates from biologic therapies in patients with psoriatic arthritis (2011) (0)
- Bastardy in the UK (2004) (0)
- P-values, Z-scores and funnel plots (2006) (0)
- Don't react, think (2009) (0)
- 57 Improving the reporting of medical risks and benefits in the media: the press alert app (2018) (0)
- Introduction to Markov chain Monte Carlo methods (2012) (0)
- Winners and Losers: Communicating the Potential Impacts of Policies: Commentary on Zeller. (2018) (0)
- VII.11 Mathematics and Medical Statistics (2010) (0)
- Authors' Reply (0)
- Impact of psoriasis on costs (2011) (0)
- Bayesian stopping rules for trials (2002) (0)
- Appendix A: Websites and Software (2004) (0)
- Was Bristol an outlier? (2001) (0)
- Making sense of uncertainty, risk and chance in public health (2015) (0)
- Classiier Recognition Rate. Misclassiication. Ambiguous Rejection Rate. Distance Rejection Rate 4. Application 4.1. Data Sets Classiier Recognition Misclassiication Rejection 5. Conclusion 3.2. Neural Network Fusion Methodology Multi-classiiers Neural Network Fusion versus Dempster-shafer's Orthogon (1995) (0)
- Funnel plot of stroke readmissions vs. number of strokes (2002) (0)
- Comments on Lindberg’s Correction for the Effects of Observer Variation on Probabilistic Diagnosis (1982) (0)
- Commentary on Piumatti et al. 2018. (2018) (0)
- Policy: Twenty tips for interpreting scientific claims This list will help non-scientists to interrogate advisers and to grasp the limitations of evidence, say (2013) (0)
- Bayesian stopping rules for trials. Authors' reply (2002) (0)
- Estimation of probability of achieving both Psoriatic Arthritis Response Criteria and Psoriasis Area and Severity Index 75 response (2011) (0)
- Algorithm sources and details (1995) (0)
- VASCULAR AGING IN MEN AND WOMEN teers (0)
- Authors' reply (0)
- Discussion of "The ASA’s p-value statement, one year on" by Robert Matthews (2017) (0)
- David Spiegelhalter's presentation (2004) (0)
- Using clinical opinion in the design of fixed-sized trials (1984) (0)
- Coping with uncertainty (in medical diagnostic computing) (1988) (0)
- Bayesian stopping rules for trials - Reply (2002) (0)
- Approaches to uncertainty for policy-makers and their advisors (2014) (0)
- Survival Models: Survival Analysis in Observational Studies (2005) (0)
- Comparison of groups when outcomes are on an ordered scale. (1988) (0)
- Was Bristol an outlier? Reply (2001) (0)
- Estimation of Psoriasis Area and Severity Index score for treatment responders in the decision model (2011) (0)
- indicatorsover-dispersion of performance (2010) (0)
- Analysis and presentation of performance indicators (2003) (0)
- Generalising the results of randomised controlled trials to general practice (2011) (0)
- Diagnosis and management of patients with bipolar disorder in primary care (2005) (0)
- Evidence synthesis overview (2011) (0)
- Estimation of the effect of Health Assessment Questionnaire and Psoriasis Area and Severity Index on utility in the decision model (2011) (0)
- Combining small-area smoking prevalence estimates from multiple surveys (2008) (0)
- Conclusions and Implications for Future Research (2004) (0)
- Dataset and software availability (1995) (0)
- Lack of cyanosis in cyanotic congenital heart disease: Authors' reply (1991) (0)
- Imperfectly observed chronic disease histories: A monte-carlo approach to inference applied to cervical cancer screening data (1991) (0)
- “Actuarial Modeling with MCMC and BUGs”, David P. M. Scollnik, April 2001 (2001) (0)
- R programme for the York economic analysis (2011) (0)
- Bayesian Networks Aplied to Therapy Monitoring (2013) (0)
- Clarifications from manufacturers (2011) (0)
- Recent developments in probabilistic reasoning in expert systems (1988) (0)
- Critique of the manufacturers' models (2011) (0)
- Tocatheterise ornottocatheterise? Anapproach based ondecision theory (1984) (0)
- Comments on An inquiry into computer understanding by Peter Cheeseman (1988) (0)
- Report of the Council for the session 2006–2007 (2007) (0)
- Use of person-years of CIN III exposure as a surrogate outcome measure in cervical cancer screening trials. (1999) (0)
- Natural history of patients with psoriatic arthritis eligible for biologic therapy (2011) (0)
- Communicating risk in primary care: what the Academy of Medical Sciences' report means in practice. (2017) (0)
- [Biostatistics and Bayes]: Comment (1990) (0)
- Reviews of cost-effectiveness studies and checklists (2011) (0)
- Sensitivity analysis comparing results from the stochastic and deterministic models (2011) (0)
- No more damned lies… (2020) (0)
- Trust in numbers 1 (2019) (0)
- Belief networks and adverse drug reactions: Discussion of papers by G. F. Cooper and D. A. Lane (1989) (0)
- Hypothesis testing: discussion (1980) (0)
- Artificial Intelligence Memoranda 1958-1979: MIT AI Laboratory.@@@Artificial Intelligence Technical Reports 1968-1983: SRI International Artificial Intelligence Center. (1988) (0)
- Perils and possibilities for communicating risk and uncertainty (2013) (0)
- Impact of Health Assessment Questionnaire on health service costs (2011) (0)
This paper list is powered by the following services:
Other Resources About David Spiegelhalter
What Schools Are Affiliated With David Spiegelhalter?
David Spiegelhalter is affiliated with the following schools:
